Health-care companies rose as traders sought out defensive sectors ahead of key inflation data.

Moderna shares slipped despite unveiling data from clinical trials showing that the biotech firm's combination Covid and flu vaccine triggered better immune responses than stand-alone shots currently on the market.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

06-10-24 1728ET